Return to search results
Quinine sulfate
Quinine Sulfate is a prescription antimalarial medication used to treat malaria. Manufactured by Lupin Pharmaceuticals, Inc., it comes as 324 mg oral capsules, packaged in bottles of 30. Approved under ANDA203112, it's available since August 2015. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Quinine Sulfate is a prescription antimalarial medication used to treat malaria. Manufactured by Lupin Pharmaceuticals, Inc., it comes as 324 mg oral capsules, packaged in bottles of 30. Approved under ANDA203112, it's available since August 2015. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Quinine sulfate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Quinine sulfate — ANDA 204372 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204372"
}
]
|
| identifier | ANDA204372 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Quinine sulfate |
